Premium
S4‐01‐04: Phase IIa clinical trial on Alzheimer's disease with NP12, a GSK3 inhibitor
Alzheimer's And DementiaPeer ReviewedTeodoro del Ser2010Journals
This content is not available in your region!
Continue researching from Zendy home
Having issues? Contact support